Showing 641 - 660 results of 3,455 for search '"peripheral"', query time: 0.07s Refine Results
  1. 641

    T118M Variant of PMP22 Gene Presents with Painful Peripheral Neuropathy and Varying Charcot-Marie-Tooth Features: A Case Series and Review of the Literature by Kwo Wei David Ho, Nivedita U. Jerath

    Published 2018-01-01
    “…All three cases presented with painful peripheral neuropathy and varying degrees of Charcot-Marie-Tooth exam features. …”
    Get full text
    Article
  2. 642
  3. 643
  4. 644

    DIAMACC: protocol of a prospective diagnostic accuracy study of the maximal systolic acceleration to detect peripheral arterial disease in patients with diabetes-related foot ulceration in the Netherlands by Jaap Hamming, Siem Willems, Abbey Schepers, Jeroen J W M Brouwers

    Published 2024-12-01
    “…Introduction Foot ulcers are one of the most serious complications of diabetes, leading to significant risks on amputation and mortality. Peripheral arterial disease (PAD) is an important factor for the development and the outcome of diabetic foot ulcers (DFU). …”
    Get full text
    Article
  5. 645

    Postoperative Outcomes of Modified Carnoy’s Solution versus 5-Fluorouracil for Chemical Cauterisation following Enucleation and Peripheral Ostectomy in Patients with Odontogenic Keratocyst: A Research Protocol by Nidhi Vijay Kumar Bodiwala, Nitin Bhola

    Published 2025-02-01
    “…Aim: To compare and evaluate the postoperative outcomes, specifically the RR, of MCS vs 5FU used for chemical cauterisation following enucleation and peripheral ostectomy in patients with OKC. Materials and Methods: An experimental in-vivo study will be conducted in the Department of Oral and Maxillofacial Surgery, Sharad Pawar Dental College, Datta Meghe Institute of Higher Education and Research (DMIHER), Sawangi (M), Wardha, Maharashtra, India, from April 2023 to March 2024. …”
    Get full text
    Article
  6. 646
  7. 647

    When specific exercise is more effective than medication - Sensorimotor training is currently the most promising option to treat and prevent chemotherapy-induced peripheral neuropathy (CIPN). by Fiona Streckmann, Maryam Balke, Céline Hammadou, Bianca Schmidli, Oliver Faude, Sarah Koch

    Published 2025-01-01
    “… Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant adverse effect of chemotherapy, negatively impacting patient quality of life. …”
    Get full text
    Article
  8. 648
  9. 649

    Effect on the size of optic nerve sheath diameter in patients undergoing surgeries under spinal anaesthesia versus peripheral nerve blocks – A randomised controlled study by Sangineni Kalyani Surya Dhana Lakshmi, A Bhargav Ram, CH Rama Krishna Prasad, Sandeep Garre, Anish Waghray

    “…Methods: Patients were randomised by a computer-generated randomisation table to receive spinal anaesthesia (Group S) or peripheral nerve block (Group P) after assessing their eligibility for the anaesthesia procedure as per the protocol. …”
    Get full text
    Article
  10. 650

    Humoral responses to SARS-CoV-2 vaccination in rituximab-treated patients depend on peripheral B cell re-population rather than the timings of the dosing by Rashwith Umesh, Aby Paul, Veena Shenoy, Sakir Ahmed, Somy Cherian, Arya Prasad, Padmanabha Shenoy

    Published 2022-01-01
    “…Conclusion: In rituximab-treated patients, humoral responses to SARS-CoV-2 vaccination depend on peripheral B-cell re-population rather than the timing of the vaccination postrituximab infusion.…”
    Get full text
    Article
  11. 651

    This is EPIC: Extensive Periphery for Impact and Control to study seabird habitat loss in and around offshore wind farms combining a peripheral control area and Bayesian statistics by Anne Grundlehner, Mardik F. Leopold, Anna Kersten

    Published 2025-03-01
    “…The model output is used for a simulation study, comparing bird densities in the potential impact area with 1000 similarly sized control areas from the peripheral control space and from these, displacement around the OWF. …”
    Get full text
    Article
  12. 652

    Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis by Xinyu Zhang, Bei Zhang, Danfei Li, Yunchao Yang, Sen Lin, Ruiqi Zhao, Yijia Li, Lisheng Peng

    Published 2025-01-01
    “…This study aims to evaluate the predictive value of peripheral blood cell counts for irAEs.MethodsStudies meeting the inclusion criteria were identified through database searches. …”
    Get full text
    Article
  13. 653
  14. 654

    Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021 by Chaoyan Yue, Qi Zhang, Fenyong Sun, Qiuhui Pan

    Published 2025-02-01
    “…Findings: This study reported the disease burden of neuroblastoma and other peripheral nervous system tumors in GBD 2021 database for the first time. …”
    Get full text
    Article
  15. 655
  16. 656

    Increased Fas and Bcl-2 Expression on Peripheral Blood T and B Lymphocytes from Juvenile-Onset Systemic Lupus Erythematosus, but not from Juvenile Rheumatoid Arthritis and Juvenile Dermatomyositis by Bernadete L. Liphaus, Maria H. B. Kiss, Solange Carrasco, Claudia Goldenstein-Schainberg

    Published 2006-01-01
    “…The aims of this study were to determine the expression of Fas antigen and Bcl-2 protein on peripheral blood T and B lymphocytes from patients with juvenile-onset systemic lupus erythematosus (JSLE), juvenile rheumatoid arthritis (JRA) and juvenile dermatomyositis (JDM). …”
    Get full text
    Article
  17. 657
  18. 658
  19. 659

    Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy by Naini Bhadri, Tejaswi Sanji, Hariprasad Madakasira Guggilla, Rema Razdan

    Published 2013-01-01
    “…Cisplatin or cis-diamminedichloroplatinum (II) (CDDP) is a cytotoxic chemotherapeutic agent with dose-dependent peripheral neuropathy as a foremost side effect characterised by ataxia, pain, and sensory impairment. …”
    Get full text
    Article
  20. 660

    Factors that influence the feasibility and implementation of a complex intervention to improve the treatment of peripheral arterial disease in primary and secondary care: a qualitative exploration of patient and provider perspectives by Athanasios Saratzis, Vanessa Lawrence, Ruth Benson, Emma Watson, Prakash Saha, Clair Le Boutillier, Bernadeta Bridgwood

    Published 2023-01-01
    “…The impetus for prioritising and delivering the intervention was further driven by its flexibility and adaptability to be tailored to the individual and to the environment.Conclusions The LEGS intervention can be tailored for use at early and late stages of peripheral arterial disease, provides an opportunity to meet patient needs and can be used to promote shared working across the primary–secondary care interface.…”
    Get full text
    Article